CD89 (FCAR) Human shRNA Plasmid Kit (Locus ID 2204)

Specifications

Product Data
Product Name	CD89 (FCAR) Human shRNA Plasmid Kit (Locus ID 2204)
Locus ID	2204
UniProt ID	P24071
Synonyms	CD89; CTB-61M7.2; FcalphaRI
Vector	pGFP-C-shLenti
Format	Lentiviral plasmids
Kit Components	FCAR - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 2204). 5µg purified plasmid DNA per construct 29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free.
RefSeq	NM_002000, NM_133269, NM_133271, NM_133272, NM_133273, NM_133274, NM_133277, NM_133278, NM_133279, NM_133280, NM_002000.1, NM_002000.2, NM_002000.3, NM_133272.1, NM_133272.2, NM_133272.3, NM_133279.1, NM_133279.2, NM_133277.1, NM_133277.2, NM_133277.3, NM_133271.1, NM_133271.2, NM_133271.3, NM_133273.1, NM_133273.2, NM_133273.3, NM_133274.1, NM_133274.2, NM_133274.3, NM_133278.1, NM_133278.2, NM_133278.3, NM_133269.1, NM_133269.2, NM_133269.3, NM_133280.1, BC027953, BC027953.1, NM_133277.4, NM_133269.4
Summary	This gene is a member of the immunoglobulin gene superfamily and encodes a receptor for the Fc region of IgA. The receptor is a transmembrane glycoprotein present on the surface of myeloid lineage cells such as neutrophils, monocytes, macrophages, and eosinophils, where it mediates immunologic responses to pathogens. It interacts with IgA-opsonized targets and triggers several immunologic defense processes, including phagocytosis, antibody-dependent cell-mediated cytotoxicity, and stimulation of the release of inflammatory mediators. Multiple alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
shRNA Design	These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service.
Performance Guaranteed	OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred).

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.